Symbol
REGENXBIO Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$8.85
Current price of the stock
$829K
Trading volume of the stock
$449.6M
Market capitalization of the company
Small Cap
Category of market capitalization
32.16%
Long-term growth mean estimate
4.67
Mean analyst rating
262.52%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
3.05
Current ratio
48.81%
Gross profit margin
-256.55%
Operating profit margin
-256.55%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-246.30%
Pretax profit margin
-246.30%
Net profit margin
-19.77%
Measures profitability relative to shareholders' equity
-19.77%
ROE excluding intangible assets
-11.48%
Measures profitability relative to total assets
-19.77%
Measures profitability relative to invested capital
0.05
Asset turnover ratio
-
Inventory turnover ratio
1.03
Receivables turnover ratio
87.79
Average number of days it takes to collect receivables
-1.76
Measures valuation relative to earnings
34.04
P/E based on future earnings estimates
5.33
Measures valuation relative to sales
1.45
Measures valuation relative to book value
-0.81
Measures valuation relative to operating cash flow
-0.78
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
